Epigenetic alterations in disseminated neuroblastoma tumour cells: Influence of TMS1 gene hypermethylation in relapse risk in NB patients

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 9, 2010, Pages 1415-1421

  Grau, E ^a,b   Martinez, F ^a   Orellana, C ^a   Canete, A ^a   Yanez Y ^a   Oltra, S ^a   Noguera, R ^a   Hernandez, M ^c   Bermudez J D ^c   Castel, V ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Disseminated disease; Metastasis; Methylation; Neuroblastoma; Prognosis factor; TMS1

Indexed keywords

ARTICLE; BONE MARROW; CANCER CELL; CANCER RELAPSE; CLINICAL ARTICLE; DISSEMINATED CANCER; DNA METHYLATION; EPIGENETICS; EVENT FREE SURVIVAL; HUMAN; HUMAN TISSUE; MGMT GENE; MYCN GENE; NEUROBLASTOMA; ONCOGENE; PRIORITY JOURNAL; PROGNOSIS; RAR GENE; REAL TIME POLYMERASE CHAIN REACTION; TMS1 GENE; BONE MARROW CANCER; CANCER STAGING; DISEASE FREE SURVIVAL; GENE EXPRESSION PROFILING; GENETIC EPIGENESIS; GENETICS; RECURRENT DISEASE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR;

CYTOSKELETON PROTEIN; PYCARD PROTEIN, HUMAN;

BONE MARROW NEOPLASMS; CYTOSKELETAL PROTEINS; DISEASE-FREE SURVIVAL; DNA METHYLATION; EPIGENESIS, GENETIC; GENE EXPRESSION PROFILING; HUMANS; NEOPLASM STAGING; NEUROBLASTOMA; PROGNOSIS; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 77955481899     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-010-0796-9     Document Type: Article

References (24)

1. M Alaminos V Davalos NK Cheung WL Gerald M Esteller 2004 Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma J Natl Cancer Inst 96 1208 1219 10.1093/jnci/djh224 1:CAS:528:DC%2BD2cXntFamtrg%3D 15316056
2. ME Alonso MJ Bello P Gonzalez-Gomez D Arjona J Lomas JM de Campos A Isla JL Sarasa JA Rey 2003 Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas Cancer Genet Cytogenet 144 134 142 10.1016/S0165-4608(02)00928-7 1:CAS:528:DC%2BD3sXltF2hsbY%3D 12850376
3. A Arapshian YS Kuppumbatti R Mira-y-Lopez 2000 Methylation of conserved CpG cites neighboring the beta retinoic acid response element may mediate retinoic acid receptor beta gene silencing in MCF-7 breast cancer cells Oncogene 19 4066 4070 10.1038/sj.onc.1203734 1:CAS:528:DC%2BD3cXmt1Ohsbk%3D 10962564
4. EF Attiyeh WB London YP Mossé Q Wang C Winter D Khazi PW McGrady RC Seeger AT Look H Shimada GM Brodeur SL Cohn KK Matthay JM Maris Children's Oncology Group 2005 Chromosome 1p and 11q deletions and outcome in neuroblastoma N Engl J Med 353 2243 2253 10.1056/NEJMoa052399 1:CAS:528:DC%2BD2MXht1Gqs7fF 16306521
5. MJ Bello ME Alonso C Aminoso NP Anselmo D Arjona P Gonzalez-Gomez I Lopez-Marin JM de Campos M Gutierrez A Isla ME Kusak L Lassaletta JL Sarasa J Vaquero C Casartelli JA Rey 2004 Hypermethylation of the DNA repair gene MGMT: association with TP53 G:C to A:T transitions in a series of 469 nervous system tumors Mutat Res 554 23 32 1:CAS:528:DC%2BD2cXmvFyrurw%3D 15450401
6. GM Brodeur RC Seeger A Barrett F Berthold RP Castleberry G D'Angio B De Bernardi AE Evans M Favrot AI Freeman G Haase O Hartmann FA Hayes L Helson J Kemshead F Lampert J Ninane H Ohkawa T Philip CR Pinkerton J Pritchard T Sawada S Siegel EI Smith Y Tsuchida PA Voute 1988 International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma J Clin Oncol 6 1874 1881 1:STN:280:DyaL1M%2FmvVSktA%3D%3D 3199170
7. SA Burchill 2004 Micrometastases in neuroblastoma: are they clinically important? J Clin Pathol 57 14 20 10.1136/jcp.57.1.14 1:STN:280: DC%2BD3snhtVKkug%3D%3D 14693828
8. H Caron 1995 Allelic loss of chromosome 1 and additional chromosome 17 material are both unfavourable prognostic markers in neuroblastoma Med Pediatr Oncol 24 215 221 10.1002/mpo.2950240402 1:STN:280:DyaK2M3hsVGmsw%3D%3D 7700165
9. H Christiansen F Lampert 1988 Tumour karyotype discriminates between good and bad prognostic outcome in neuroblastoma Br J Cancer 57 121 126 1:STN:280:DyaL1c7mtleitA%3D%3D 3348945
10. M Esteller SR Hamilton PC Burger SB Baylin JG Herman 1999 Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia Cancer Res 59 793 797 1:CAS:528:DyaK1MXht1Sjurk%3D 10029064
11. P Gonzalez-Gomez MJ Bello J Lomas D Arjona ME Alonso C Aminoso I Lopez-Marin NP Anselmo JL Sarasa M Gutierrez C Casartelli JA Rey 2003 Aberrant methylation of multiple genes in neuroblastic tumours. relationship with MYCN amplification and allelic status at 1p Eur J Cancer 39 1478 1485 10.1016/S0959-8049(03)00312-5 1:CAS:528:DC%2BD3sXkvVWjsrs%3D 12826052
12. T Ivanova A Petrenko T Gritsko S Vinokourova E Eshilev V Kobzeva F Kisseljov N Kisseljova 2002 Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer BMC Cancer 21 2 4
13. Y Kaneko N Kanda N Maseki M Sakurai Y Tsuchida T Takeda I Okabe M Sakurai 1987 Different karyotypic patterns in early and advanced stage neuroblastomas Cancer Res 47 311 318 1:STN:280:DyaL2s%2Fnsl2ktQ%3D%3D 3791218
14. C Komine T Watanabe Y Katayama A Yoshino T Yokoyama T Fukushima 2003 Promoter hypermethylation of the DNA repair gene O6-methylguanine-DNA methyltransferase is an independent predictor of shortened progression free survival in patients with low-grade diffuse astrocytomas Brain Pathol 13 176 184 1:CAS:528:DC%2BD3sXjsF2gurg%3D 12744471
15. P Lázcoz J Muñoz M Nistal A Pestaña IJ Encío JS Castresana 2007 Loss of heterozygosity and microsatellite instability on chromosome arm 10q in neuroblastoma Cancer Genet Cytogenet 174 1 8 10.1016/j.cancergencyto.2006.08.014 17350460
16. XF Liu SG Zhu H Zhang Z Xu HL Su SJ Li XT Zhou 2006 The methylation status of the TMS1/ASC gene in cholangiocarcinoma and its clinical significance Hepatobiliary Pancreat Dis Int 5 449 453 1:CAS:528:DC%2BD28XpvVent74%3D 16911948
17. JM Maris MD Hogarty R Bagatell SL Cohn 2007 Neuroblastoma Lancet 369 2106 2120 10.1016/S0140-6736(07)60983-0 1:CAS:528:DC%2BD2sXmvVKqtb0%3D 17586306
18. R Martinez G Schackert M Esteller 2007 Hypermethylation of the proapoptotic gene TMS1/ASC: prognostic importance in glioblastoma multiforme J Neurooncol 82 133 139 10.1007/s11060-006-9264-4 1:CAS:528:DC%2BD2sXltFKhtr0%3D 17048097
19. S Oltra F Martinez C Orellana E Grau JM Fernandez A Cañete V Castel 2005 The doublecortin gene, a new molecular marker to detect minimal residual disease in neuroblastoma Diagn Mol Pathol 14 53 57 10.1097/01.pas.0000149876. 32376.c0 15714065
20. XC Qian TP Brent 1997 Methylation hot spots in the 5′ flanking region denote silencing of the O6-methylguanine-DNA methyltransferase gene Cancer Res 57 3672 3677 1:CAS:528:DyaK2sXlvFentro%3D 9288770
21. M Schwab F Westermann B Hero F Berthold 2003 Neuroblastoma: biology and molecular and chromosomal pathology Lancet Oncol 4 472 480 10.1016/S1470- 2045(03)01166-5 1:CAS:528:DC%2BD3sXlvFGjurw%3D 12901961
22. RC Seeger GM Brodeur H Sather A Dalton SE Siegel KY Wong D Hammond 1985 Association of multiple copies of the Nmyc oncogene with rapid progression of neuroblastomas N Engl J Med 313 1111 1116 1:STN:280:DyaL28%2FhsValsQ%3D%3D 4047115
23. C Zhang H Li G Zhou Q Zhang T Zhang J Li J Zhang J Hou CT Liew D Yin 2007 Transcriptional silencing of the TMS1/ASC tumour suppressor gene by an epigenetic mechanism in hepatocellular carcinoma cells J Pathol 212 134 142 10.1002/path.2173 1:CAS:528:DC%2BD2sXnt1Gkt7s%3D 17471463
24. J Zhu X Yao 2007 Use of DNA methylation for cancer detection and molecular classification J Biochem Mol Biol 40 135 141 1:CAS:528: DC%2BD2sXkt1Krtbs%3D 17394761